Metoclopramide Noridem

Metoclopramide, the active ingredient in Metoclopramide Noridem, is a dopamine D2 receptor antagonist presented as an injection solution for intramuscular and intravenous use. It treats nausea and vomiting, including postoperative and chemotherapy‑induced, and facilitates gastric emptying in conditions such as gastroparesis.

GNH USA supplies Metoclopramide Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, transplant centres and pharmacies worldwide.

Metoclopramide Noridem acts on dopamine pathways to control nausea, vomiting and gastric motility. - Nausea and vomiting: reduces frequency and severity of episodes in various clinical settings. - Postoperative nausea and vomiting: prevents and treats nausea after surgical procedures. - Chemotherapy‑induced nausea and vomiting: controls acute and delayed phases of treatment‑related emesis. - Gastroparesis: enhances gastric emptying and alleviates related symptoms. - Pre‑endoscopic procedures: facilitates gastric emptying to improve procedural tolerance.

Metoclopramide Noridem may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: mild sedation that may affect alertness. - Fatigue: reduced energy levels during treatment. - Diarrhea: loose stools occurring after administration. - Restlessness: feeling of inner tension or agitation.

Serious or Rare Side Effects: - Extrapyramidal reactions: muscle rigidity, tremor, or dystonia. - Tardive dyskinesia: involuntary movements with prolonged use. - Neuroleptic malignant syndrome: high fever with severe muscle rigidity. - Severe hypotension: marked drop in blood pressure requiring medical attention.

Before using Metoclopramide Noridem, consider the following precautions. - Assess patient history: check for prior extrapyramidal reactions or movement disorders. - Monitor for depression: observe mood changes during therapy. - Use caution in renal impairment: dose may need adjustment based on kidney function. - Avoid in patients with known hypersensitivity to metoclopramide. - Pregnancy and lactation: safety not established; use only if benefits outweigh potential risks. - Store at ambient temperature: keep in original container, protect from light and moisture.

Metoclopramide Noridem can interact with several medicines.

Major Interactions (Avoid): - Anticholinergic agents: may reduce pro‑kinetic effect. - CYP2D6 inhibitors (e.g., fluoxetine): increase plasma levels of metoclopramide. - Dopamine agonists (e.g., levodopa): antagonize therapeutic effect. - MAO inhibitors: risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Sedatives: additive central nervous system depression. - Alcohol: may enhance drowsiness. - Other antiemetics (e.g., ondansetron): possible additive effect on QT interval.